← All trials
NCT00389168
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 1995
- Primary completion
- Apr 1, 1997
- Completion date
- Apr 1, 1997
- First posted
- —
- Last posted
- —
- Enrollment
- 115
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Karolinska InstituteLead sponsor
- Bristol-Myers SquibbCollaborator
- SanofiCollaborator
- Swedish Heart Lung FoundationCollaborator
- Karolinska InstituteStudy chair
- Karolinska InstituteReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.